Thc analytical performance of a new immunometric CK-MB assay from Novo Biolabs was evaluated in three hospitals. Comparisons were made with another immunometric assay, an immune inhibition/precipitation technique, an immune inhibition method, and a column separation method. The Novo assay exhibited good precision (CV 3-7%) at all concentration levels tested (6-1 50pg/L) and was found to be linear over the range 0-200pg/L. Comparison of the Novo kit with the other methods using patients' sera showed acceptable correlation between the methods over a wide concentration range ( r = 0.96-0.99). We conclude that the assay is a useful adjunct to the specific measurement of CK-MB, particularly in routine laboratories with a high throughput of such determinations.
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The use of CK-MB (isoenzyme 2 of ATP: creatine N-phosphotransferase, EC 2.7.3.2) analysis in the diagnosis and management of myocardial injury has been well documented.' Assays for CK-MB can be divided into three categories: those measuring enzyme activity following isolation of the CK-MB isoenzyme or inhibition of other isoenzymes, those measuring the antigen concentration of the isoenzyme by means of specific antibodies and isoenzyme electrophoresis. Substantial differences in results may exist between various assays leading to misunderstanding and creating potentially dangerous situations when patients are transferred from one hospital to another, and it is therefore important to evaluate newly developed assays against accepted methods. In this report we compare the analytical performace of the new Novo Biolabs 'Novoclone' CK-MB kit with four methods routinely used in our laboratories.
MATERIALS AND METHODS

Specimens
In each of the three participating centres, Correspondence: M r R W Wulkan heparinized blood samples were taken from patients suspected to have myocardial injury. Plasma was assayed with the Novo method and three of the reference procedures (the participant with the Roche method used serum). Samples were kept frozen at -20°C until assayed and were thawed only once. For the column method samples were kept at 4°C and assayed on the day of arrival. In each of the three centres the samples were assayed with the Novo method and with the in-house routine method. For precision studies we used lyophilized bovine commercial serum controls and pooled patients' plasma or serum. Samples were diluted with saline (9 g/L) if necessary.
E L S A method (Novo)
The NovocloneTM CK-MB assay from the Novo Biolabs (Cambridge, UK) was used in accordance with the manufacturer's protocol. The sample and a peroxidase-labelled antibody directed at the CK-M subunit are incubated simultaneously in microtiter plate wells precoated with an antibody directed towards the CK-B subunit. After washing, the remaining enzyme activity is a measure of the initial CK-M B concentration. All measurements were made in duplicate. Calibrator target values were ob- 
Immune inhibition method from Boehringer
MonotestTM CK-M R method (NAC-activated) from Boehringer Mannheim (Mannheim, Germany) was used according to the manufacturer's protocol. In this method, the CK-M moiety is inhibited by a specific antibody and the remaining enzyme activity (CK-B moiety) is measured at 30°C and multiplied by two to give total CK-MB activity.
Statistical analysis
For statistical evaluation bivariate orthogonal regression' was used, as well as the nonparametrical rcgression procedure of Bablok and Passing. 3.4
RESULTS AND DISCUSSION Precision
Between-run and within-run coefficients of variation were calculated from values obtained with either commercial control sera (Novo Biolabs) or home-made serum pools. The coefficients of variation of the Novo method were generally found to be below 5%, except in the low concentration range. Precision estimates were carried out in each laboratory at various concentration levels (Table I) .
The observed between-run CVs measured at high and low concentrations are in good agreement with those stated by the manufacturer and were not significantly different when tested using a two-sided F-test. A comparison between all kits is given in Table 2 .
Linearity
A pool of patients' samples with high CK-MB concentrations was made by each laboratory and diluted with zero standard to produce concentrations of approximately 25, 50, 75, 100, 150, and 200pg/L as measured by the Novo method. The Novo assay is reported to be linear over the range of 0-200pg/L and this was confirmed by our observations.
Method comparison
In each laboratory 200 patients' samples were selected to be assayed for CK-MB by the Novo method and the routine method. The concentrations were chosen to obtain 50 measurements in the range O-lOpg/L, 50 measurements between 10 and 25pg/L, and 100 measurements with values above 25pg/L as measured with the Novo assay.
Regression analysis was performed according to Bablok and Passing.3 The method is nonparametric and does not require constant CVs over a wide concentration range. Results are given in Table 3 and shown graphically in Fig. 1 . In the comparison of the two ELISA assays, i.e. the Novo versus the Hybritech method, a slope of 1.35 was obtained. Both these assays express results in mass units. The activity assays (ionexchange and Boehringer) had similar slopes (2.2, 2.5) indicating they are quite comparable. The high slope of the Novo-Roche comparison is partly due to the lower temperature (25°C) and reduces to 3.31 when the results are converted to 30°C, the temperature used in the other assays. These two methods also express results in different units. The correlation coefficients of all methods versus Novo are good, being 0.96-0.98.
In contrast to this, the inserts in Fig. 1 show an appreciable scatter of measurements in the low range, especially with the Boehringer-Novo comparison. The reason for this is not totally clear, because the coefficients of variation are not sufficiently high to explain all of the scatter: 10% in the range of 5-15U/L for the Boehringer method, and 7% at 6pg/L for the Novo method.
Table4 shows the number of discrepant results (those falling within the reference limits by one method and above the upper reference limit by the other), using the limits given by the manufac-
